25 May 2012

Competition dents Alliance Pharma

16/01/2012 Robert Tyerman

Alliance Pharma (APHY) says 2011's results will show a 7.5 per cent turnover fall to £46 million, reflecting increased competition.

In a cautious trading update, the acquisutive Chippenham-based compay, whose first-half pre-tax profits rose 17 per cent to £7 million on turnover up 4.3 per cent to £24.4 million, indicates tougher competition and a trend towards uncoated tablets further dented sales of former mainstay, Deltacortril, a treatment for inflammatory and auto-immune conditions, which fell from £4.7 million in the first half year to £1.1 million in the second.

AIM-quoted Alliance, steered by chief executive John Dawson, says it expects last year's pre-tax profits to come out in line with market estimates, which see a fall from £12.9 million in 2010 to around £11.3 million. The company reports 14 per per cent sales growth in Ireland for its Nu-Seals heart attack and stroke treatment, despite a price cut early in the year and the launch of a generic competitor in the autumn, but remains 'cautious' about 2012 because of continuing efforts by the Dublin government to reduce its medicines bill.

However, Alliance argues the impact of its takeovers last year, including mouth ulcer treatment Abesol, Ashton & Parsons powder for infants teething or with cholic and six acne-related products linked to a treatment called Rizuderm, combined with 'efficiency measures and other cost savings', should 'largely compensate' for Deltacortril and Nu-Seals setbacks. The company owns or licences the rights to more than 50 pharmaceutical products and says it 'continues to explore opportunities to expand the range.'

Growth Company Investor first recommended Alliance shares at 4.38p in 2009, before suggesting partial profit taking at 29.25p last September. Having traded between 37.13p and 26.25p over the past year, the shares now change hands at 28.75p, down 3p this morning, valuing the company at £69 million and yielding nearly 2 per cent.

Long term prospects look fair. But there might be further weakness before that.

Tags: Abesol mouth ulcer treatment, AIM market, Deltacortril anti-inflammatory t, John Dawson, Rizuderm, Takeovers

Sector: Pharmaceuticals & Biotechnology

Companies: Alliance Pharma

Achieve impressive returns

Gain instant access to some of the best-performing and fastest growing companies in the small cap arena

Click here

Achieve impressive returns on the go

Gain instant access to some of the best-performing and fastest growing companies in the small cap arena. Sign up NOW!

Institutional Investors in AIM 2011 - New Report

This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.

Coverage of AIM, techMARK and PLUS Markets

Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.

If you're interested in business tax updates visit our specialist tax guide website.

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Gulf starts at Sheikh Adi-2 25/05/2012

Iraq-focused oil explorer Gulf Keystone Petroleum (GKP) has begun drilling at the Sheikh Adi-2 well in the Sheikh Adi block.

Tags: Doing business in Iraq, Drilling on AIM, Oil on AIM

Sector: Oil & Gas Producers

Companies: Gulf Keystone Petroleum

Shell considers Cove 24/05/2012

Oil giant Shell is extending its offer period for Mozambique-focused Cove Energy (COV) after having its bid trumped by Thai government-owned PTT Exploration & Production.

Tags: Bid trumped, Doing business in Mozambique, Oil giants on AIM, Takeovers and bids

Sector: Oil & Gas Producers

Companies: Royal Dutch Shell 'A' , Cove Energy

Roxi reaches 1,360 metres 23/05/2012

Kazakhstan-focused Roxi Petroleum (RXP) has declared that its NK7 well in the Galaz aea has drilled to a depth of 1,360 metres.

Tags: AIM ventures, Doing business in Kazakhstan, Oil on AIM

Cluff Natural Resources joins AIM 22/05/2012

Steered by sector veteran Algy Cluff, North-Sea focused cash shell Cluff Natural Resources (CNR) has joined AIM.

Tags: Entrepreneurs on AIM, Gold mining, Oil and gas on AIM

Red Emperor exercises Shabeel 21/05/2012

Somalia-focused oil explorer Red Emperor Resources (RMP) has exercised its option to take part in the drilling of the Shabeel North well.

Tags: Business in the Puntland, Doing business in Somalia, Drilling for oil & gas, Oil on AIM

Sector: Oil & Gas Producers

Companies: Red Emperor Resources

Heritage happy in Iraq 18/05/2012

Oil concern Heritage Oil (HOIL) has reported its Miran West-3 well in Iraq could deliver 1,000 barrels per day of condensate.

Tags: Doing business in Iraq, Oil on the full list, Oil production, Target depth

Sector: Oil & Gas Producers

Companies: Heritage Oil

More News

Sectors